Crohn's Disease Patients Treated With Adalimumab Benefit From Co-Treatment With Immunomodulators: Results From a Nationwide Study in the Netherlands

Authors :: Mirthe E. van der Valk
Martijn G.H. van Oijen
Peter D. Siersema
Marije J. Ammerlaan
Bas Oldenburg
Source :: Gastroenterology. 140:S-263
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: medicine.medical_specialty
Crohn's disease
Hepatology
business.industry
Internal medicine
Gastroenterology
Adalimumab
medicine
business
medicine.disease
medicine.drug
Surgery

Full Text Access

Tools